$MCHX

MARCHEX INC (MCHX): Results of Operations and Financial Condition

MARCHEX INC (MCHX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mchx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Marchex Announces Second Quarter 2026 Financial Results Reports Improved Profitability and Early Momentum Following Archenia Acquisition SEATTLE, WA – August 12, 2026 – Marchex, Inc. (NASDAQ: MCHX), a vertically focused, AI-d

Original reporting
Published Aug 12, 2026, 8:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 8:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$MCHX
Neutral
medium confidence
Mentioned
$MCHX
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MCHXNeutralMed
01

Why it matters

The filing provides a near-term decision point via reported Q2 performance and explicit pro forma guidance for the quarter ending Sept. 30, 2026, tied to early adoption of combined Marchex and Archenia solutions.

02

Market read

Traders can reassess MCHX’s post-deal trajectory using the disclosed Q2 metrics and the stated pro forma Q3 2026 revenue and adjusted EBITDA ranges.

03

What to watch

Customer adoption is described as early and concentrated in the top 100 customers, so investors may discount scalability until broader customer conversion and retention metrics are evidenced.

Relevance 7/10Novelty 8/10Timing: after-hours filing today, ahead of next earnings release in early November 2026

Background

Marchex completed its previously announced acquisition of Archenia on July 1, 2026, and this 8-K reports Q2 results plus pro forma combined metrics and outlook.

Company-level read

Ticker impact

$MCHXNeutralMedium confidence
Context

Marchex reports Q2 2026 revenue of $11.0M and a net loss of $0.4M, plus pro forma guidance for Q3 2026 after the July 1 Archenia close.

Expected impact

Likely two-way reaction depending on how investors weigh the revenue decline versus the improved adjusted EBITDA and the credibility of the post-acquisition pro forma trajectory.

Evidence & confidence

The filing is a primary disclosure (8-K with Exhibit 99.1) and includes both reported Q2 metrics and forward-looking pro forma ranges for the quarter ending Sept. 30, 2026. However, the revenue is down year over year and the adjusted EBITDA includes acquisition-related costs, which can temper enthusiasm.

Market effects

Signals continued consolidation and monetization of AI-driven conversation analytics and customer acquisition tooling, potentially supporting sentiment for small-cap adtech/AI services peers.

No clear regional spillover beyond US small-cap tech/marketing services sentiment.

Limited direct global impact; primarily affects US-listed AI customer acquisition analytics market expectations.

Counterpoint

The revenue decline and net loss persist, and the adjusted EBITDA improvement is partly driven by acquisition and reorganization costs, so the pro forma trajectory may not translate into durable operating leverage.

Key entities

  • Marchex, Inc.

    NASDAQ-listed AI-driven conversation analytics and customer acquisition optimization company reporting Q2 2026 results and pro forma outlook post-Archenia acquisition.

  • Archenia

    Acquired July 1, 2026, adding AI-powered lead qualification, conversational IVR, and performance marketing infrastructure to Marchex’s platform.

  • Russell Horowitz

    Chairman of Marchex, quoted on strategy and early customer adoption following the Archenia acquisition.

Related articles

$AUNAMed

Auna (AUNA) Q2 2026 Earnings Call Transcript

Auna (AUNA) reported Q2 2026 results with 9% revenue growth driven by volume and higher complexity services. Adjusted EBITDA declined 9% due to margin pressures in Mexico and Colombia, and billing penalties in Peru. Mexico saw 7% surgery and 20% oncology volume growth, while Peru achieved 8% revenue growth. Colombia's adjusted EBITDA increased 18% sequentially. Leverage decreased to 3.6x, and cash increased 43% year-over-year.

$MRCYHighAI 8/10

Mercury Systems (MRCY) Q4 2026 Earnings Call Transcript

Mercury Systems (MRCY) reported Q4 2026 earnings with record bookings of $660M, revenue of $290M, and EBITDA margin of 16.7%. The company increased its organic growth outlook for FY 2027, citing strong demand and execution. Key drivers include increased production volumes, new development programs, and defense budget tailwinds. The company also announced a strategic agreement with Palantir to enhance operations.

$MZTIMedAI 8/10

The Marzetti Co (MZTI) (Q4 2026) Earnings Call Highlights: Record Year Fueled

The Marzetti Co (MZTI) reported a 2.2% decline in Q4 net sales due to reduced club channel sales and pipeline build comparisons. A Cyclospora outbreak is expected to cause a 250 basis point net sales headwind in Q1 2027. Core retail business, excluding Bachan's, saw a 7% organic volume decline. Commodity inflation is forecasted at 5% for fiscal 2027. The company expects 100 basis points of gross margin growth in fiscal 2027, driven by Bachan's integration and cost savings. CEO Dave Ciesinski ant

$TOLHighAI 8/10

Toll Brothers (TOL) Q3 2026 Earnings Call Transcript

Toll Brothers (TOL) reported Q3 2026 earnings, highlighting a 5% increase in net agreements and $2.5B in sales. The company maintained strong margins and reaffirmed full-year guidance, including $10.5B in home sales revenue. TOL returned $231M to shareholders and increased its stock repurchase projection to $700M. The luxury move-up segment drove growth, with 61% of revenue. The company's financial strength and strategic land investments support continued growth.